×
About 860 results

ALLMedicine™ Blepharitis Center

Research & Reviews  225 results

Tinea blepharitis and follicular conjunctivitis in a child.
https://doi.org/10.1016/j.jaapos.2021.04.004
Journal of AAPOS : the Official Publication of the Americ... Bothun CE, Decanini A et. al.

Jun 24th, 2021 - Trichophyton tonsurans is a fungal species that frequently causes tinea capitis (ringworm), a skin infection found in children. We report a case of unilateral blepharoconjunctivitis due to tinea capitis in a previously healthy 8-year-old boy. Alth...

Plug-related canaliculitis: a rare or underdiagnosed disease?
https://doi.org/10.1080/08164622.2021.1927675
Clinical & Experimental Optometry; Yeh TC, Hou TY et. al.

Jun 18th, 2021 - Conjunctivitis, chalazion and blepharitis are routinely managed by optometrists. However, it is especially important to consider the diagnosis of canaliculitis in patients with chronic or recurrent conditions. This study aimed to report the clinic...

Oral antibiotics for chronic blepharitis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189606
The Cochrane Database of Systematic Reviews; Onghanseng N, Ng SM et. al.

Jun 9th, 2021 - Posterior blepharitis is common and causes ocular surface and lid damage as well as discomfort. It affects 37% to 47% of all ophthalmology patients; its incidence increasing with age. It is a multifactorial disease associated with multiple other p...

Corneal Effects of Tea Tree Oil.
https://doi.org/10.1097/ICO.0000000000002776
Cornea Tharmarajah B, Coroneo MT

Jun 2nd, 2021 - The purpose of this study is to report a case of corneal epithelial defects resulting from topical treatment of blepharitis with tea tree oil (TTO). A 44-year-old man with a 1 year history of blepharitis non-responsive to eyelid hygiene was found ...

Chalazion: racial risk factors for formation, recurrence, and surgical intervention.
https://doi.org/10.1016/j.jcjo.2021.04.023
Canadian Journal of Ophthalmology. Journal Canadien D'oph... Evans J, Vo KBH et. al.

Jun 1st, 2021 - An association between race and formation of chalazion has yet to be objectively established. This study investigates race as a risk factor for chalazion and chalazion surgery. Understanding racial risk factors in formation of chalazion, recurrent...

see more →

Guidelines  1 results

Blepharitis Preferred Practice Pattern®.
https://doi.org/10.1016/j.ophtha.2018.10.019
Ophthalmology Amescua G, Akpek EK et. al.

Oct 27th, 2018 - Blepharitis Preferred Practice Pattern®.|2018|Amescua G,Akpek EK,Farid M,Garcia-Ferrer FJ,Lin A,|organization & administration,therapeutic use,diagnosis,drug therapy,diagnosis,therapeutic use,pathology,organization & administration,standards,stand...

see more →

Drugs  79 results see all →

Clinicaltrials.gov  15 results

To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis
https://clinicaltrials.gov/ct2/show/NCT03301844

Dec 18th, 2019 - Blepharitis is the most common condition in patients seeking an eye examination due to discomfort or eye irritation. Treatment of blepharitis is recommended even in mild cases as chronic inflammation may cause permanent damage to the Meibomian gla...

Topical IL-1-Ra for Treatment of Posterior Blepharitis
https://clinicaltrials.gov/ct2/show/NCT00681109

Jan 18th, 2018 - The purpose of this study is to determine the effectiveness and safety of Topical Interleukin-1-Receptor Antagonist in treatment of signs and symptoms of posterior blepharitis.

Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients
https://clinicaltrials.gov/ct2/show/NCT02503956

Oct 1st, 2017 - The efficacy of punctal dilatation with insertion of perforated punctal plugs for the management of acquired punctal stenosis due to allergic conjunctivitis. Acquired punctal stenosis is a condition in which the external opening of the lacrimal ca...

Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
https://clinicaltrials.gov/ct2/show/NCT01456780

Jul 31st, 2017 - Posterior blepharitis is a common chronic eyelid condition that is described as generalized inflammation of the posterior lid margin and associated with inflammation of the ocular surface and with symptoms of burning, irritation, and discomfort. P...

Demodex Blepharitis Treatment Study
https://clinicaltrials.gov/ct2/show/NCT01647217

Jul 25th, 2017 - Demodex blepharitis is one of the most common causes of chronic blepharitis. The investigators preliminary clinical study showed that lid scrub with TTO was effective in resolving chronic blepharoconjunctivitis; however, it was not convenient for ...

see more →

News  21 results

Fast Five Quiz: Neuro-Ophthalmologic Manifestations of Multiple Sclerosis
https://reference.medscape.com/viewarticle/924764_2

Apr 7th, 2020 - Figure 1. Optic neuritis with drusen (stereo image). The most common visual disturbance associated with MS is ON or inflammation of the optic nerve characterized by a subacute unilateral vision loss, flashes of light, and typically pain with eye m...

Fast Five Quiz: Pathogenesis and Presentation of Rosacea
https://reference.medscape.com/viewarticle/912487_4

Jul 23rd, 2019 - Answer 3/5 Which of the following is the most predominant sign of erythematotelangiectatic rosacea? Your peers chose: Central facial flushing often accompanied with stinging or burning 0% Small erythematous papules surmounted by pinpoint pustules ...

Fast Five Quiz: Ocular Rosacea
https://reference.medscape.com/viewarticle/913170_6

Jun 3rd, 2019 - Because there is no known cure for ocular rosacea, the goals of patient management are prophylactic and palliative in nature. A stepwise approach is recommended, beginning with eyelid hygiene and artificial tears. The use of hot compresses and/or ...

Rosacea: 5 Things to Know
https://www.medscape.com/viewarticle/902020

Sep 18th, 2018 - Rosacea is a chronic inflammatory skin disease that centers on the pilosebaceous units and presents with at least one of the following features: Centrofacial erythema with telangiectatic mats and flushing; Inflammatory lesions (papules, pustules, ...

FDA Clears New Treatment for Dry Eye (Cequa)
https://www.medscape.com/viewarticle/900888

Aug 16th, 2018 - The US Food and Drug Administration (FDA) has approved cyclosporine A ophthalmic solution 0.09% (Cequa, Sun Pharmaceuticals) to increase tear production in patients with keratoconjunctivitis sicca (dry eye), the company has announced. Cequa is a p...

see more →

Patient Education  3 results see all →